The clinical Phase 2b study of its novel Rivelin patch to be tested in patients suffering from Oral Lichen Planus.

Trial Profile

The clinical Phase 2b study of its novel Rivelin patch to be tested in patients suffering from Oral Lichen Planus.

Planning
Phase of Trial: Phase II

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs Clobetasol (Primary)
  • Indications Lichen planus
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jan 2018 New trial record
    • 11 Jan 2018 According to a Dermtreat media release, the study is expected to last for 6-9 months with study results being available in 1H 2019.
    • 11 Jan 2018 According to a Dermtreat media release, dermtreat has finalized and submitted the IND and CTAs respectively to commence this Phase 2b clinical study with the first patient planned to be enrolled in April 2018..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top